Jong-Gu Kang
Chief Executive Officer bei BIOTOXTECH CO., LTD.
Vermögen: 9 Mio $ am 31.03.2024
Profil
Jong-Gu Kang is currently the Chairman & Chief Executive Officer at Biotoxtech Co., Ltd., the Co-Chief Executive Officer at Scas-BTT Bioanalysis Co., Ltd., the Chief Executive Officer at Tru Technologies Ltd., the Chief Executive Officer & Director at Keyfron Bio Co., Ltd., and the Director at Korean Association For Laboratory Animal Science.
He started his career in 1990 as a Professor at Chungbuk National University.
He has also held positions as the Chief Executive Officer at Sejong Venture Partners Co., Ltd.
and as a Non-Executive Director at ENZYCHEM LIFESCIENCES Corp.
Dr. Kang holds a doctorate degree from the University of Tokyo and undergraduate and graduate degrees from Seoul National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOTOXTECH CO., LTD.
12,76% | 29.03.2024 | 2 035 965 ( 12,76% ) | 9 Mio $ | 31.03.2024 |
Aktive Positionen von Jong-Gu Kang
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOTOXTECH CO., LTD. | Chief Executive Officer | 01.01.2000 |
| Chungbuk National University | Corporate Officer/Principal | 30.05.2011 |
Scas-BTT Bioanalysis Co., Ltd.
 Scas-BTT Bioanalysis Co., Ltd. Scas-BTT Bioanalysis Co., Ltd. is engaged in Testing and Analysis Services of Composition and Purity of Materials. The company was founded on May 2, 2011 and is headquartered in Cheongju, South Korea. | Chief Executive Officer | - |
| Korean Association For Laboratory Animal Science | Director/Board Member | - |
Tru Technologies Ltd.
 Tru Technologies Ltd. Packaged SoftwareTechnology Services Tru Technologies Ltd. develops and operates securities finance software solutions. The company is based in Seoul, South Korea. The CEOs are Jae-Woo Ha, Jong-Gu Kang. The South Korean company was founded in 2019. | Chief Executive Officer | - |
| Keyfron Bio Co., Ltd. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Jong-Gu Kang
| Unternehmen | Position | Ende |
|---|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Director/Board Member | - |
Sejong Venture Partners Co., Ltd.
 Sejong Venture Partners Co., Ltd. Investment ManagersFinance Sejong Venture Partners Co Ltd (Sejong Venture) is a venture capital firm founded in 2013. The firm is headquartered in Seoul, South Korea. | Chief Executive Officer | - |
Ausbildung von Jong-Gu Kang
| University of Tokyo | Doctorate Degree |
| Seoul National University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ENZYCHEM LIFESCIENCES CORPORATION | Health Technology |
| BIOTOXTECH CO., LTD. | Commercial Services |
| Private Unternehmen | 5 |
|---|---|
Scas-BTT Bioanalysis Co., Ltd.
Scas-BTT Bioanalysis Co., Ltd. Scas-BTT Bioanalysis Co., Ltd. is engaged in Testing and Analysis Services of Composition and Purity of Materials. The company was founded on May 2, 2011 and is headquartered in Cheongju, South Korea. | |
Sejong Venture Partners Co., Ltd.
Sejong Venture Partners Co., Ltd. Investment ManagersFinance Sejong Venture Partners Co Ltd (Sejong Venture) is a venture capital firm founded in 2013. The firm is headquartered in Seoul, South Korea. | Finance |
| Korean Association For Laboratory Animal Science | |
Tru Technologies Ltd.
Tru Technologies Ltd. Packaged SoftwareTechnology Services Tru Technologies Ltd. develops and operates securities finance software solutions. The company is based in Seoul, South Korea. The CEOs are Jae-Woo Ha, Jong-Gu Kang. The South Korean company was founded in 2019. | Technology Services |
| Keyfron Bio Co., Ltd. |
